PHILADELPHIA--(BUSINESS WIRE)--MacroArray Technologies, LLC today announced it has signed a licensing agreement with Abbott for MacroArray’s antibody test for prostate cancer. As part of the agreement, Abbott will develop and market the PCADM-1 test, an innovative assay to detect the novel PCADM-1 prostate specific protein in urine.
